Mutations of BRCA1, BRCA2, and PALB2 genes in breast tumor tissue: Relationship with the effectiveness of neoadjuvant chemotherapy and disease prognosis
It has been shown that the loss of function of the BRCA1, BRCA2, and PALB2 genes due to a number of hereditary mutations or chromosomal aberrations can affect the effectiveness of chemotherapy treatment and disease prognosis in patients with various types of cancer, and in particular in breast cance...
| Published in: | Genes Vol. 14, № 8. P. 1554 (1-20) |
|---|---|
| Other Authors: | Tsyganov, Matvey M., Sorokovikova, Sofia S., Lutzkaya, Elizaveta A., Ibragimova, Marina K. |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001132674 |
Similar Items
- Microarray analysis of DNA copy number aberration of the BRCA1 gene in breast tumor: correlation with the efficacy of neoadjuvant chemotherapy
- New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients
-
Связь экспрессии гена BRCA1 в опухоли молочной железы с эффектом неоадъювантной химиотерапии
by: Перминова, Елена Евгеньевна - New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families
- Анализ кодирующих областей гена BRCA1 в опухоли молочной железы
